Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: Results from a systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 102, Issue 3, 2007, Pages 662-667

  Dorn, Spencer D ^a,b   Sandler, Robert S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 33847253913     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.01018.x     Document Type: Article

References (63)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
2. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 1999;100:96-102.
3. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11.
4. Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med 2005;2:29-36.
5. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 2006;113:2128-34.
6. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998;279:1477-82.
7. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
8. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005;352:29-38.
9. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-8.
10. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
11. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
12. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
13. del Rincon IJ, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
14. McEntegart A, Capell HA, Creran D, et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001;40:640-4.
15. Warrington KJ, Kent PD, Frye RL, et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: A case control study. Arthritis Res Ther 2005;7:R984-91.
16. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115-20.
17. Loftus EV Jr. Inflammatory bowel disease extending its reach. Gastroenterology 2005;129:1117-20.
18. Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:839-46.
19. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542-8.
20. Efremidis M, Prappa E, Kardaras F. Acute myocardial infarction in a young patient during an exacerbation of ulcerative colitis. Int J Cardiol 1999;70:211-2.
21. Mutlu B, Ermeydan CM, Enc F, et al. Acute myocardial infarction in a young woman with severe ulcerative colitis. Int J Cardiol 2002;83:183-5.
22. Chetri K, Ghoshal UC, Somani SK, et al. Common carotid artery occlusion causing cerebral infarction in ulcerative colitis. Indian J Gastroenterol 2002;21:122-3.
23. Calderon R, Cruz-Correa MR, Torres EA. Cerebral thrombosis associated with active Crohn's disease. P R Health Sci J 1998;17:293-5.
24. Schneiderman JH, Sharpe JA, Sutton DM. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 1979;5:331-7.
25. Danese S, Fiocchi C. Atherosclerosis and inflammatory bowel disease: Sharing a common pathogenic pathway? Circulation 2003;107:e52.
26. Rachapalli SM. Inflammatory bowel diseases and atherosclerosis: Do we need more studies? Inflamm Bowel Dis 2005;11:705.
27. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-151.
28. Wolters FL, Russel MG, Stockbrugger RW. Systematic review: Has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004;20:483-96.
29. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2-15.
30. Hennekens CH, Burning JE. Epidemiology in medicine. Philadelphia: Lippincott Williams & Wilkins, 1987.
31. Newman S. Biostatistical methods in epidemiology. New York: John Wiley & Sons, Inc., 2001.
32. Wong O, Raabe GK. Application of meta-analysis in reviewing occupational cohort studies. Occup Environ Med 1996;53:793-800.
33. Mayberry JF, Newcombe RG, Rhodes J. Mortality in Crohn's disease. Q J Med 1980;49:63-8.
34. Prior P, Gyde S, Cooke WT, et al. Mortality in Crohn's disease. Gastroenterology 1981;80:307-12.
35. Gyde S, Prior P, Dew MJ, et al. Mortality in ulcerative colitis. Gastroenterology 1982;83:36-43.
36. Stonnington CM, Phillips SF, Zinsmeister AR, et al. Prognosis of chronic ulcerative colitis in a community. Gut 1987;28:1261-6.
37. Weterman IT, Biemond I, Pena AS. Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut 1990;31:1387-90.
38. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: A population-based study. Gastroenterology 1992;103:954-60.
39. Probert CS, Jayanthi V, Wicks AC, et al. Mortality from Crohn's disease in Leicestershire, 1972-1989: An epidemiological community based study. Gut 1992;33:1226-8.
40. Probert CS, Jayanthi V, Wicks AC, et al. Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci 1993;38:538-41.
41. Stewenius J, Adnerhill I, Anderson H, et al. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmo, Sweden. Int J Colorectal Dis 1995;10:117-22.
42. Cottone M, Magliocco A, Rosselli M, et al. Mortality in patients with Crohn's disease. Scand J Gastroenterol 1996;31:372-5.
43. Persson PG, Bernell O, Leijonmarck CE, et al. Survival and cause-specific mortality in inflammatory bowel disease: A population-based cohort study. Gastroenterology 1996;110:1339-45.
44. Saro GC, Lacort FM, Arguelles FG, et al. Mortality and causes of death in patients with chronic inflammatory bowel disease in Gijon, Asturias (Spain). Rev Esp Enferm Dig 1999;91:199-208.
45. Davoli M, Prantera C, Berto E, et al. Mortality among patients with ulcerative colitis: Rome 1970-1989. Eur J Epidemiol 1997;13:189-94.
46. Viscido A, Bagnardi V, Sturniolo GC, et al. Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis 2001;33:686-92.
47. Uno H, Yao T, Matsui T, et al. Mortality and cause of death in Japanese patients with Crohn's disease. Dis Colon Rectum 2003;46:S15-21.
48. Farrokhyar F, Swarbrick ET, Grace RH, et al. Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England. Am J Gastroenterol 2001;96:501-7.
49. Katoh H, Iwane S, Munakata A, et al. Long-term prognosis of patients with ulcerative colitis in Japan. J Epidemiol 2000;10:48-54.
50. Jess T, Winther KV, Munkholm P, et al. Mortality and causes of death in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002;122:1808-14.
51. Winther KV, Jess T, Langholz E, et al. Survival and cause-specific mortality in ulcerative colitis: Follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003;125:1576-82.
52. Masala G, Bagnoli S, Ceroti M, et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: The Florence IBD study 1978-2001. Gut 2004;53:1309-13.
53. Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause-specific mortality in patients with inflammatory bowel disease: A long-term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55:1248-54.
54. Wolters FL, Russel MG, Sijbrandij J, et al. Crohn's disease: Increased mortality 10 years after diagnosis in a Europewide population based cohort. Gut 2006;55:510-8.
55. Brostrom O, Monsen U, Nordenwall B, et al. Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979. Scand J Gastroenterol 1987;22:907-13.
56. Palli D, Trallori G, Saieva C, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence study. Gut 1998;42:175-9.
57. Ergin A, Muntner P, Sherwin R, et al. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med 2004;117:219-27.
58. Devroede G. Complementarity of statistics and balance of diseases. Gastroenterology 1982;83:142-3.
59. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000;54:514-21.
60. Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: A population-based study. Am J Gastroenterol 2003;98:1556-62.
61. Behn A, Ur E. The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 2006;21:353-60.
62. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-59.
63. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclooxygenase-2 inhibitors and traditional non-steroidal antiinflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-8.